Results of the viscoelastic testing, standard and specific markers for non-severe and severe CAD groups
| Normal (n=80) | Unobstructed CAD (n=88) | Unobstructed (n=168) | Obstructive CAD (n=83) | p Value | |
| df | 1.728±0.052 | 1.735±0.053 | 1.732±0.052 | 1.749±0.057 | 0.028 |
| IL-6 | 50.1±5.0 | 52.1±4.3 | 51.6±4.1 | 67.6±7.5 | 0.38 |
| MPO | 4541±1450 | 4563±1471 | 4544±1456 | 4636±1482 | 0.66 |
| CRP | 3.6±3.2 | 3.7±3.0 | 3.7±2.8 | 3.7±3.0 | 0.75 |
| Hb (g/dL) | 14.0±1.2 | 14.3±1.3 | 14.1±1.3 | 14.2±1.2 | 0.45 |
| Plt (×109/L) | 263±67 | 253±69 | 258±67 | 249±53 | 0.22 |
| HCT (g/g) | 0.418±0.033 | 0.425±0.035 | 0.422±0.035 | 0.437±0.035 | 0.24 |
| PT (s) | 10.5±0.4 | 10.5±0.5 | 10.5±0.4 | 10.6±0.5 | 0.057 |
| APTT (s) | 25.8±2.1 | 25.8±1.9 | 25.8±2.0 | 26.2±1.9 | 0.13 |
| FBG (g/L) | 3.3±0.6 | 3.4±0.7 | 3.3±0.6 | 3.4±0.7 | 0.26 |
| DD* | 94 (IQR 71–147) | 122 (IQR 81–178) | 110 (IQR 74–167) | 131 (IQR 80–209) | 0.095 |
| TG | 137±44 | 119±50 | 128±76 | 136±93 | 0.51 |
| FVIII | 132±44 | 138±46 | 135±45 | 135±38 | 0.99 |
| Multiplate ADP | 85.3±32.2 | 77.1±27.5 | 81.4±29.8 | 76.9±28.5 | 0.24 |
| Multiplate ASPI* | 28 (IQR 13–70) | 30 (IQR 18–83) | 29.0 (IQR 15.8–78.1) | 25.4 (IQR 18.0–64.5) | 0.41 |
*Median and interquartile values reported.
APPT, activated partial thromboplastin time; CAD, coronary artery disease; CRP, C-reactive protein; DD, D-Dimer; FBG, fibrinogen; FVIII, Ffactor VIII; Hb, haemoglobin; HCT, haematocrit; IL-6, interleukin 6; MPO, myeloperoxidase; Plt, platelet count; PT, prothrombin time; TG, thrombin generation.